The global microcarrier market was surpassed at USD 1.93 billion in 2021 and is expected to hit around USD 5.10 billion by 2030, growing at a CAGR of 11.4% from 2022 to 2030.
Microcarrier is a small bead-like material used to immobilize biocatalysts or to adhere to the growing cells to be cultivated in bioreactors. It acts like a support matrix. The cells grow on the microcarriers which are spherical and called beads. It provides the approach for the expansion of the cell culture system which is beneficial for gene and cell-based therapies and research activities. Microcarrier has wide application in vaccine production using packaging cell lines. The most commonly used cell types are Vero cells. Microarray technology also has advantages in the pharmaceutical and biotech sector, as follows –
Scope of The Report
Report Coverage | Details |
Market Size in 2021 | USD 1.93 billion |
Revenue Forecast by 2030 | USD 5.10 billion |
Growth rate from 2022 to 2030 | CAGR of 11.4% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segmentation | Product Type, Application, End-user, Region |
Companies Covered |
Sartorius AG, GE Healthcare, Thermo Fisher Scientific Inc., Corning Incorporated, Merck KGaA, Danaher Corporation, Lonza, Eppendorf AG, Becton, Dickinson and Company, HiMedia Laboratories, others |
Vaccine production and cell therapy are the major driving factors for enhancing the growth of microcarrier markets. Vaccines produced from microcarriers or cell cultures is the most efficient method as the process has a short lead time and large production quantity. Clinical trials have also proved that this is a safe and effective process. Moreover, the funding from the private as well as public sector companies is increasing for cell-based vaccine production. The commercially available microcarriers in the market are alginate-based, dextran-based, collagen-based, and polystyrene-based. Some examples of such microcarriers are GEM, Cytodex, GE Healthcare, Cultispher, Percell, and SoloHill Engineering. On the other hand, the downstream process cost of the microcarrier culture is high. This can be one of the restraints for the microcarrier markets for small-scale companies with low budgets. Recently, Sartorius Stedim Biotech (SSB) launched a mini bioreactor vessel for the production of vaccines using microcarrier cell culture. The rise in cancer cases which is observed globally is boosting the growth of markets.
The market is segmented based on product type, application, end-user, and region. The market is segmented based on the product type into equipment, consumables, and microcarrier beads. Based on the application segment it is further segmented into gene therapy, vaccine manufacturing, biologics manufacturing, tissue engineering, and regenerative medicines among others. End users like pharmaceutical and biotechnology industries, CROs, and Research Institutes hold the major markets as they contribute to the invention, discovery, and improvement of human lives.
Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. As per the research, North America holds the major market due to the higher prevalence of chronic diseases. Also, North America has a well-developed healthcare infrastructure and growing healthcare sector which contributes to the market growth. This is due to the increasing investments and funding by private and public companies along with research institutes. The European market is also projected to expand due to increasing investment by companies in the region. Recently, Sartorius, Germany has obtained the SoloHill portfolio of Danaher Corporation, thus expanding its microcarrier portfolio. The company has also introduced a mini microcarrier bioreactor vessel. ABL Europe and Sartorius have signed an agreement for implementing the manufacturing facility in Strasbourg.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Microcarrier Market
5.1. COVID-19 Landscape: Microcarrier Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Microcarrier Market, By Product
8.1. Microcarrier Market, by Product, 2022-2030
8.1.1 Equipment
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Consumables
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Microcarrier Beads
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Microcarrier Market, By Application
9.1. Microcarrier Market, by Application, 2022-2030
9.1.1. Vaccine Manufacturing
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Cell and Gene Therapy
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Biologics
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Manufacturing
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Tissue Engineering
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Microcarrier Market, By End-user
10.1. Microcarrier Market, by End-user, 2022-2030
10.1.1. Academic and Research Institutes
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Pharmaceutical and Biotechnology Companies
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Contract Research Organizations
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Microcarrier Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by End-user (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End-user (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End-user (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End-user (2017-2030)
Chapter 12. Company Profiles
12.1. Sartorius AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Thermo Fisher Scientific Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Corning Incorporated
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Merck KGaA
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danaher Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Lonza
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Eppendorf AG
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Becton
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Dickinson and Company
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms